All Type of News
Korean medicines deemed inexpensive
A survey of 202 medicinal products showed that Korean medicines are reasonable by global standards.
The Korea Pharmaceutical Manufacturers Association reported that 202 out of 1,299 generic products are cheaper tha...
Foreign GMP inspection to be expanded, KFDA officials say
The Korea Food and Drug Administration will strengthen its on-spot inspection on foreign GMP facilities as part of efforts to ensure the quality of medicinal products.
So far, the KFDA has conducted its on-spot ins...
Government to back new drug development
The Ministry of Education, Science and Technology unveiled its plan to promote a government sponsored funding in support of the identification, research and development of biotechnology-based novel drugs and treatment...
Yungjin to launch generic ActosYungjin Pharm says it will launch the first generic version of Actos (pioglitazone hydrochloride), Glitzone 15 mg (823 won per tablet) from August 1.
Actos is a medication th...
|
Handok enters licensing agreement for Cetrorelix with AEterma Zentaris
Handok Pharm announced on July 14 that it has entered into a licensing agreement with Canada-based AEterma Zentaris Inc. for Cetrorelix (cetrorelix pamoate), a novel investigational luteinizing hormone-releasing hormo...
Multinationals are likely to leave Korea
Korea will face an exodus of foreign-invested pharmaceutical firms operating here, as many are complaining about the government’s unilateral assessment of conventional medicines and price cut, causing a sharp drop in ...
Hydrogel wound dressing market warming up
The domestic market is gaining momentum with a new comer 3M who sees opportunities in the field where larger companies are rushing into the game after the market success by Ildong’s Medifoam in 2003.
3M says its Te...
Korean drug companies urged to explore overseas markets
Korean pharmaceutical firms should look to advance into overseas market, amid the government’s relentless price cut and fiercer competition in already saturated domestic market, according to a local analyst.
Analys...
CJ breaks ground for cGMP plantA ground-breaking ceremony for construction of a new cGMP plant was held in Osung complex of North Chungcheong Province on July 15, according to CJ Cheiljedang.
CJ said it w...
|
Korea Kolmar to develop topical agent for treatment of osteoporosis
Korea Kolmar is aiming to develop a new topical drug containing calcitonin and bisphosphonates to treat osteoporosis by spending 3.5 billion won for the next three years, under the joint collaboration with the Korea R...
